Derek Neilson is a Rare/Genetic physician affiliated with Barrow Neurological Institute. OpenAlex indexes 55 publications with 1,465 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1920 E Cambridge Ave Ste 304
Phoenix, AZ 85006
Telephone
602-933-4363Registry record last updated 10 Jul 2018.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Spark Therapeutics, Inc.Program year20211 payment
- Ultragenyx Pharmaceutical Inc.Program year20211 payment
- BioMarin Pharmaceutical Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Carnitine Analog100%Levocarnitine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A clinical and genotype-phenotype analysis of MACF1 variants
The American Journal of Human Genetics
2025 - Clinical utility of runs of homozygosity in the identification of genetic causes in individuals with rare diseases
Genetics in Medicine Open
2025 - Losartan Treatment Reduces Esophageal Eosinophilic Inflammation in a Subset of Eosinophilic Esophagitis
The Journal of Allergy and Clinical Immunology In Practice
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lawton, MD
Barrow Neurological Institute
Marwan Sabbagh, MD
Barrow Neurological Institute
Yonas Geda, MD, MSc
Barrow Neurological Institute
Nader Sanai, MD
Barrow Neurological Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”